论文部分内容阅读
麸质敏感性肠病(gluten-sensitive enter-opathy,简称GSE)并非少见.70年代英美两国的发生率为1/3000～1/2000.80年代瑞典和西爱尔兰的发生率增至1/950～1/400.在我国报道很少,诊断比较可靠者仅有陈忠贵和刘开玲等各报告1例,均经小肠活检和无麸质饮食治疗有效所证实.但今后随着小肠活检的广泛开展,必将有更多的病例出现.为了对它加深认识,本文对其发病机制与诊断治疗等加以复习.
The incidence of gluten-sensitive enter-opathy (GSE) is not uncommon in the United States and the United States in the 1970s, with rates ranging from 1 in 3000 to 1 in 2000. The incidence of Sweden and West Ireland in the 1980s increased to 1 in 950, 1 / 400. There are few reports in China, more reliable diagnosis of only Chen Zhonggui and Liu Kai Ling and other reports of 1 case, both confirmed by the small intestine biopsy and gluten-free diet, but in the future with the extensive development of intestinal biopsy, will There will be more cases.In order to deepen understanding of it, this article reviews its pathogenesis and diagnosis and treatment.